UBS Group
APLMW icon

UBS Group’s Apollomics Inc Warrant APLMW Stock Holding History

UBS Group’s Portfolio APLMW Stock Details APLMW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,348
Closed -$27 – 9897
2024
Q3 		$27 Buy
+3,348
New +$39 ﹤0.01% 9286
2023
Q4 		– Sell
-100
Closed -$4 – 9272
2023
Q3 		$4 Buy
+100
New +$7 ﹤0.01% 9293

Other funds holding APLMW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group's APLMW Position: Q4 2024 in Review

UBS Group sold out of Apollomics Inc Warrant (APLMW) in Q4 2024, closing a stake of 3,348 shares — an estimated $27 sold.

UBS Group first reported a position in APLMW in Q3 2023 and held it in 2 quarters. The position peaked at $27 in Q3 2024. 21 funds tracked by Wall St. Rank hold APLMW as of Q4 2024.

  • UBS Group reported no remaining Apollomics Inc Warrant position as of Q4 2024 after selling out during the quarter.
  • UBS Group sold 3,348 Apollomics Inc Warrant shares in Q4 2024, an estimated $27.
  • UBS Group first reported a position in Apollomics Inc Warrant in Q3 2023 and held it in 2 quarters.
  • UBS Group's Apollomics Inc Warrant position peaked at $27 in Q3 2024.
  • 21 funds tracked by Wall St. Rank held Apollomics Inc Warrant as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.